3SBio Inc (1530) – Strategy, SWOT and Corporate Finance Report

3SBio Inc (1530) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

3SBio Inc (3SBio) is a biotechnology company that discovers, develops, manufactures and markets biopharmaceutical products. The company develops recombinant or genetically engineered, protein-based products and other pharmaceutical product candidates to meet significant unmet medical needs in the areas of cancer and its supportive care, nephrology, dermatology, and other disease conditions. The company distributes its products to hospitals, clinics and dialysis centers in China. The company sells its products in Colombia, Brazil, Costa Rica, Egypt, Dominican Republic, Guatemala, El Salvador, Mongolia, Laos, Pakistan, Sri Lanka, Myanmar, the Philippines, Paraguay, Thailand, Trinidad and Tobago. 3SBio is headquartered in Shenyang, Liaoning, China.

Scope

• Detailed information on 3SBio Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting 3SBio Inc in the form of a SWOT analysis

• An in-depth view of the business model of 3SBio Inc including a breakdown and examination of key business segments

• News about 3SBio Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of 3SBio Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess 3SBio Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on 3SBio Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

CapitalBio Corp

Harbin Pharmaceutical Group Holding Co Ltd

Hubei Guangji Pharmaceutical Co Ltd

Shandong Kexing Bioproducts Co Ltd

Nanjing Hencer Pharmaceutical Co Ltd

Zhejiang Raybow Pharmaceutical Co Ltd

China Intertrade Ltd

China Intertrade Ltd

Harbin Pharmaceutical Group Holding Co Ltd

Hubei Guangji Pharmaceutical Co Ltd

Kexing Biopharm Co Ltd

Zhejiang Raybow Pharmaceutical Co Ltd

CapitalBio Corp

Nanjing Hencer Pharmaceutical Co Ltd

Kirin Brewery Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

3SBio Inc - Key Facts

3SBio Inc - Key Employees

3SBio Inc - Key Employee Biographies

3SBio Inc - Major Products and Services

3SBio Inc - History

3SBio Inc - Company Statement

3SBio Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

3SBio Inc - Business Description

Other Break-up: Contract development and manufacturing operation business

Performance

Other Break-up: Sale of Biopharmaceuticals

Performance

Geographical Segment: Mainland China

Performance

Geographical Segment: Others

Performance

R&D Overview

3SBio Inc - Corporate Strategy

3SBio Inc - SWOT Analysis

SWOT Analysis - Overview

3SBio Inc - Strengths

3SBio Inc - Weaknesses

3SBio Inc - Opportunities

3SBio Inc - Threats

3SBio Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

3SBio Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 28, 2023: 3SBio: Appointment of Chief Financial Officer

Jul 28, 2023: 3SBio Announces Appointment of Chief Financial Officer

Mar 29, 2022: 3SBio announces annual results announcement for the year ended 31 December 2021

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

3SBio Inc, Key Facts

3SBio Inc, Key Employees

3SBio Inc, Key Employee Biographies

3SBio Inc, Major Products and Services

3SBio Inc, History

3SBio Inc, Other Locations

3SBio Inc, Subsidiaries

3SBio Inc, Key Competitors

3SBio Inc, Ratios based on current share price

3SBio Inc, Annual Ratios

3SBio Inc, Annual Ratios (Cont…1)

3SBio Inc, Annual Ratios (Cont…2)

3SBio Inc, Interim Ratios

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

3SBio Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

3SBio Inc, Performance Chart (2018 – 2022)

3SBio Inc, Ratio Charts

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

3SBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports